| IP |
| Therosteon has reached an agreement with the Erasmus Medical Center to obtain worldwide exclusive rights on all IP, which has been and will be generated in the group of Professor Hans van Leeuwen in the field of bone diseases. This includes a.o. 3 patent applications in the field osteoblast biology, therapeutic interventions and novel drug targets. The Company will be actively looking to further broaden and strengthen its patent portfolio. |
Newsflash
Nov 5. Dec 15. |
